A double‐blind, randomized trial of intravenous versus intramuscular antivenom for Red‐back spider envenoming

Abstract

Red-back spider antivenom was initially effective by both i.m. and i.v. routes. The study generates the hypothesis that at 24 h, significantly more patients are pain-free with i.v. administration. Definitive recommendations on the optimal route of administration of RBS AV await the results of further studies.